CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 110 enrolled
Drug / intervention
ropivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02139982
NCT02139982Phase 1Completed

The Study of Regional Hemodynamic Changes After Specific Brachial Plexus Block by Ultrasound Guidance

Wenzhou Medical University·interventional·Posted May 16, 2014·Updated Aug 1, 2014

In Brief

A Phase 1 clinical trial evaluating specific nerve block and ropivacaine for Upper Limb Nerve Block. Completed, enrolled 110 participants across 1 site.

Detailed Summary

Phase 1 Sympathetic block leads to vasodilatation and increases in blood flow. However, regional hemodynamic changes of radial and ulnar artery after specific nerve block of brachial plexus remains unclear. The aim of the study is to assess the effect of specific nerve block of brachial plexus on hemodynamics of upper extremity, and provides evidence for further research in patient undergoing microvascular surgery. Phase 2 There is no literature about dose-finding studies of sympathetic block after brachial plexus block. Little is known regarding the relationship between concentration of local anaesthetic and vasodilation of upper extremity. The aim of this randomized, double-blind, prospective dose-response study is to determine the ED50 and ED95 of ropivacaine in sympathetic block of upper extremity after supraclavicular block

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 16, 2014
Enrollment StartJan 1, 2011
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.1 years ago

Interventions

specific nerve blockprocedure

specific nerve blocks of the musculocutaneous, radial, ulnar, or median nerves at axillary region

ropivacainedrug

Different concentration of ropivacaine